Abstract
CD70 is up-regulated in several malignancies, where it induces cytotoxic effects on B and T lymphocytes, leading to immune escape. Novel therapeutic agents targeting CD70 have entered clinical trials. We characterized expression of CD70 protein in renal cell carcinoma specimens of various histologic subtypes and assessed their prognostic value and association with clinical/pathologic variables. We used tissue microarrays containing 330 cases using a novel fluorescent immunohistochemistry-based method of Automated Quantitative Analysis of in situ protein expression. The mean expression of CD70 was almost twice as high in tumors relative to normal tissue (P
Author supplied keywords
Cite
CITATION STYLE
Jilaveanu, L. B., Sznol, J., Aziz, S. A., Duchen, D., Kluger, H. M., & Camp, R. L. (2012). CD70 expression patterns in renal cell carcinoma. Human Pathology, 43(9), 1394–1399. https://doi.org/10.1016/j.humpath.2011.10.014
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.